麻荆止咳颗粒治疗风痰阻肺型咳嗽的效果观察
Observation on the Therapeutic Effect of Ma Jing Zhi Ke Granules in Treating Cough of Wind-Phlegm Obstructing the Lung Type
DOI: 10.12677/acm.2026.1662337, PDF,    科研立项经费支持
作者: 叶燕燕, 王世聪:福建中医药大学附属第二人民医院呼吸科,福建 福州;黄依晴*:福建中医药大学附属第二人民医院老年病科,福建 福州
关键词: 咳嗽风痰阻肺型麻荆止咳颗粒炎性反应Cough Wind-Phlegm Obstructing the Lung Type Ma Jing Zhi Ke Granules Inflammatory Response
摘要: 目的:探讨麻荆止咳颗粒治疗风痰阻肺型咳嗽的临床疗效。方法:选取本院2024年1月~2025年6月诊断风痰阻肺型咳嗽的患者122例,采用随机分组方式分为两组:一周治疗组85例、一月治疗组37例,两组均在给予抗感染、止咳化痰等常规西药基础治疗上,联合麻荆止咳颗粒口服。比较两组治疗前后临床疗效、中医症候积分、炎症指标情况。结果:一周治疗组总有效率88.24% (75/85),一月治疗组总有效率91.89% (34/37)。一周治疗组与一月治疗组治疗后咳嗽、咯痰症候积分均小于治疗前(P < 0.05)。一周治疗组治疗后血WBC、NC、NE%、LY%、NC/LC水平均较治疗前下降(P < 0.05);一月治疗组血CRP水平较治疗前下降(P < 0.05)。结论:西药基础上加用麻荆止咳颗粒对于炎症指标及症候改善均有疗效,其中延长治疗周期可提升风痰阻肺型咳嗽的治疗效果,改善患者症状。
Abstract: Objective: To explore the clinical efficacy of Ma Jing Zhi Ke Granules in the treatment of cough due to wind-phlegm obstructing the lung. Methods: A total of 122 patients diagnosed with cough due to wind-phlegm obstructing the lung in our hospital from January 2024 to June 2025 were selected and randomly divided into two groups: the one-week treatment group (85 cases)and the one-month treatment group (37 cases). Both groups were treated with conventional Western medicine, such as anti-infection and cough suppression and expectoration, and were additionally administered Ma Jing Zhi Ke Granules orally. The clinical efficacy, TCM syndrome scores, and inflammatory indicators before and after treatment were compared between the two groups. Results: The total effective rate of the one-week treatment group was 88.24% (75/85), and that of the one-month treatment group was 91.89% (34/37). The cough and expectoration syndrome scores of both groups after treatment were lower than those before treatment (P < 0.05). The levels of blood WBC, NC, NE%, LY%, and NC/LC in the one-week treatment group decreased after treatment compared with those before treatment (P < 0.05); the CRP level in the one-month treatment group decreased after treatment compared with that before treatment (P < 0.05). Conclusion: The addition of Ma Jing Zhi Ke Granules to conventional Western medicine has therapeutic effects on inflammatory indicators and syndrome improvement. Extending the treatment period can enhance the therapeutic effect on cough due to wind-phlegm obstructing the lung and improve the symptoms of patients.
文章引用:叶燕燕, 黄依晴, 王世聪. 麻荆止咳颗粒治疗风痰阻肺型咳嗽的效果观察[J]. 临床医学进展, 2026, 16(6): 1278-1284. https://doi.org/10.12677/acm.2026.1662337

参考文献

[1] 徐玥瑾, 张学智. 旋杏二陈汤治疗风痰阻肺型慢性咳嗽临床研究[J]. 中华中医药杂志, 2020, 35(11): 5877-5879.
[2] 陈家卫, 蔡穗珍. 基于胸腺基质淋巴细胞生成素/蛋白酶激活受体2/瞬时电位受体香草酸受体1/活化T细胞的核因子信号通路探讨麻荆止咳颗粒治疗咳嗽变异性哮喘的作用机制[J]. 中医临床研究, 2023, 15(28): 69-74.
[3] 陈志斌, 周春权, 朱涓等. 麻荆止咳颗粒对咳嗽变异性哮喘豚鼠凋亡抑制基因Bcl-2表达的影响[J]. 中医临床研究, 2018, 10(36): 56-59.
[4] 王世聪, 叶燕燕, 卢峰. 麻荆止咳颗粒治疗风盛挛急型咳嗽变异性哮喘30例[J]. 福建中医药, 2023, 54(2): 63-64+67.
[5] 林文娟. 麻荆止咳颗粒治疗风邪犯肺型感染后咳嗽的疗效观察[D]: [硕士学位论文]. 福州: 福建中医药大学, 2019.
[6] 罗继红. 咳平汤治疗风邪犯肺型咳嗽变异性哮喘临床观察[D]: [硕士学位论文]. 福州: 福建中医学院, 2009.
[7] 中华医学会呼吸病学分会哮喘学组. 中国难治性慢性咳嗽的诊断与治疗专家共识[J]. 中华结核和呼吸杂志, 2021, 44(8): 689-698.
[8] 中华医学会呼吸病学分会. 轻度支气管哮喘诊断与治疗中国专家共识(2023) [J]. 中华结核和呼吸杂志, 2023, 46(9): 880-896.
[9] 国家技术监督局. GB/T 16751.2-1997中医临床诊疗术语: 证候部分[J]. 北京: 中国标准出版社, 1997.
[10] Canning, B.J., Chang, A.B., Bolser, D.C., Smith, J.A., Mazzone, S.B., McGarvey, L., et al. (2014) Anatomy and Neurophysiology of Cough: CHEST Guideline and Expert Panel Report. Chest, 146, 1633-1648. [Google Scholar] [CrossRef] [PubMed]
[11] 栾哲宇, 杨晓, 师艺航, 等. 基于咳嗽敏感性增高探讨风咳“风邪伏肺”的物质基础及中医治疗[J]. 现代中西医结合杂志, 2022, 31(2): 207-210+223.
[12] 赵克明, 孙小蕾, 丁莉莉, 等. 国医大师晁恩祥治疗感染后咳嗽经验[J]. 山东中医杂志, 2025, 44(11): 1250-1254.
[13] 石召华, 胡铭洁, 蔺珂昕, 等. 中医药治疗难治性慢性咳嗽的作用机制及研究进展[J]. 亚太传统医药, 2026, 22(6): 218-228.
[14] 王小兰, 菅丽鹤, 袁培培, 等. 基于升降浮沉药性理论比较草麻黄、中麻黄与木贼麻黄对风水水肿大鼠模型的影响[J]. 中药药理与临床, 2025, 41(5): 87-92+21.
[15] 海日捍, 李学红, 于敖敏, 等. 荆芥挥发油化学成分、药理作用及应用研究进展[J/OL]. 中西医结合慢性病杂志, 1-19.
https://link.cnki.net/urlid/21.1621.R.20251124.1431.014, 2026-01-08.
[16] 蒋云姣. 白细胞计数、中性粒细胞计数、淋巴细胞计数及中性粒细胞与淋巴细胞比值在鉴别病毒性和细菌性肺炎患者中的应用价值探析[J]. 中国典型病例大全, 2026, 20(1): 167-172.
[17] 袁晔, 陈洁, 孙霖, 等. 中医证型和NLR对肝癌免疫治疗疗效的预测作用[J]. 中医研究, 2024, 37(6): 19-23.
[18] 黄依晴, 叶燕燕, 王世聪, 等. 麻荆止咳颗粒对咳嗽变异性哮喘大鼠血清IL-6、TNF-α含量和气道管壁厚度的影响[J]. 中医研究, 2025, 38(6): 53-57.
[19] 陈汝满, 白亚飞, 王春莉, 等. 中性粒细胞/淋巴细胞比值和C反应蛋白/白蛋白比值对维持性血液透析患者全因死亡预测价值: 随访5年的队列研究[J]. 中国全科医学, 2024, 27(35): 4397-4402+4411.
[20] 张杰, 刘静, 常玲玲, 等. 预后营养指数联合中性粒细胞与淋巴细胞比值评估维持性血液透析患者衰弱的临床价值及预测模型的改进[J]. 临床肾脏病杂志, 2026, 26(1): 7-15.